Drug-Induced Pulmonary Fibrosis: National Database Analysis
Our study demonstrated increased reporting on PF in the National Pharmacovigilance database from 2019 to 2024. We revealed outstanding results for the role of antineoplastic and immunomodulating agents in PF development.
Authors
- S. К. Zyryanov (ORCID: https://orcid.org/0000-0002-6348-6867)
- О. И. Бутранова (ORCID: https://orcid.org/0000-0001-7729-2169)
- I. L. Asetskaya (ORCID: https://orcid.org/0000-0002-6641-7752)
- V. A. Polivanov (ORCID: https://orcid.org/0009-0009-5110-978X)
- G. N. Gildeeva (ORCID: https://orcid.org/0000-0002-2537-2850)
- Anna Abramova (ORCID: https://orcid.org/0000-0002-7960-1006)
- E. N. Terekhina (ORCID: https://orcid.org/0000-0003-1272-8042)
- Yury Kustov (ORCID: https://orcid.org/0009-0002-4859-4322)
Institutions
- Peoples' Friendship University of Russia (RU)
- Sechenov University (RU)
- City Clinical Hospital No. 2 (RU)
- Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (RU)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3390/biomedicines12122650
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.42